Customer Connect Login
FIND AN ACCREDITED PROVIDER
Opioid treatment programs provide medication-assisted treatment (MAT) for persons diagnosed with opioid-use disorder. The Substance Abuse and Mental Health Services Administration (SAMHSA ) explains, "MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders. Research shows that when treating substance-use disorders, a combination of medication and behavioral therapies is most successful. Medication assisted treatment (MAT) is clinically driven with a focus on individualized patient care."
The duration of treatment should be based on the needs of the persons served and take into consideration the benefits of MAT. The medications used to achieve treatment goals include methadone and buprenorphine, which are approved by the Food and Drug Administration (FDA) for the use in the treatment of opioid-use disorder.
Services are directed at reducing or eliminating the use of illicit drugs, criminal activity, and/or the spread of infectious disease while improving the quality of life and functioning of the persons served. Opioid treatment programs follow rehabilitation stages of sufficient duration to meet the needs of persons served.
In November 2001, SAMHSA announced that CARF was an approved accreditation provider for opioid treatment programs providing outpatient, residential, and detoxification services in the United States.
SAMHSA's approval of CARF accreditation is part of the federal government's 42 Code of Federal Regulations, Part 8, which shifts regulatory oversight from the FDA to a national accreditation model under SAMHSA/Center for Substance Abuse Treatment (CSAT) oversight.
Please refer to the program descriptions for further details.
For more information on CARF opioid treatment program accreditation, please email email@example.com or call toll free (888) 281-6531.
© 2017 CARF International. All rights reserved.
Legal notices  Careers  Contact Us